Canadian public places high priority on drugs’ safety, effectiveness, and certainty of evidence

25 March 2019 - Survey reveals top values for drug coverage decision making. ...

Read more →

One Canadian payer's experience with biosimilars

25 March 2019 - Much of the discussion about biosimilar uptake revolves around challenges in the United States, but other ...

Read more →

A patient’s journey with melanoma and drug coverage concerns

22 March 2019 - Living her best life with her husband Jeremy, Karen Formosa was looking forward to retiring within ...

Read more →

Ontario may lift ban preventing major pharmacies from selling private-label generic drugs

21 March 2019 - Ontario Premier Doug Ford’s government is considering lifting a ban that prevents major pharmacy chains from ...

Read more →

Why Ontario parents could soon be paying more for prescription drugs

22 March 2019 - Some Ontario parents will be paying more for their kids’ medicine starting next month. Young adults ...

Read more →

Where is the champion for Pharmacare?

20 March 2019 - With the possible exception of a few drug company executives, Canadians overwhelmingly support universal pharmacare — ...

Read more →

National drug agency touted as building block of Pharmacare plan

19 March 2019 - The Trudeau Liberals’ new budget promises a new agency to buy drugs in bulk and cut ...

Read more →

Roche and the pan-Canadian Pharmaceutical Alliance complete negotiations for multiple sclerosis treatment, Ocrevus (ocrelizumab), for both RRMS and PPMS

19 March 2019 - Roche Canada today announced that it has completed negotiations with the pan-Canadian Pharmaceutical Alliance for a ...

Read more →

Canada to create national drug agency to help cut cost of medicines

20 March 2019 - Canada will create a national drug agency to help cut the cost of prescription medications as part ...

Read more →

New treatment option now available in Canada for newly diagnosed patients with advanced lung cancer

18 March 2019 - Keytruda (pembrolizumab) in combination with pemetrexed and platinum chemotherapy reduced the risk of death by half compared ...

Read more →

The impact of pharmaceutical rebates on patients’ drug expenditures

18 March 2019 - The drug-pricing landscape in Canada is complex, with 4 different agencies and each provincial, territorial and federal ...

Read more →

Health Canada begins release of clinical data on drugs and devices

14 March 2019 - Health Canada launched two public databases on Wednesday as the first step in making clinical information ...

Read more →

The Liberals’ plan for Pharmacare? We’re still waiting

14 March 2019 - The Trudeau government is edging closer to announcing its proposals for some kind of national drug ...

Read more →

Foquest receives approval for expanded indication for children and adolescents with ADHD

12 March 2019 - First and only methylphenidate product approved in Canada that provides control of ADHD symptoms throughout the day. ...

Read more →

Imbruvica (ibrutinib) combination regimen to treat Waldenström's macroglobulinemia approved through Health Canada priority review

8 March 2019 - Imbruvica plus rituximab showed significant improvement in progression-free survival versus rituximab monotherapy in Waldenström's macroglobulinemia, a ...

Read more →